• Pharma
  • November 16, 2018
  • 96 views
Post GST, pharma sector grew 6 percent till May-end: Mansukh Mandaviya

After the implementation of GST, the pharmaceutical sector grew 6 per cent to Rs 1,31,312 crore on a year-on-year basis till May 31, Minister of State for Chemicals and Fertilisers…

  • Pharma
  • November 16, 2018
  • 170 views
Dangerous Misuse Of Antibiotics, WHO warned

WHO ( World Health Organization) shared warning about the misuse of antibiotics as WHO mapped the consumption graph and it is dangerously high in many of the countries while a…

  • Pharma
  • November 15, 2018
  • 121 views
Patients and industry fret over drug supplies, if no Brexit deal

By Ben Hirschler Consumers and the pharmaceuticals industry alike are anxious about medicine supplies, if there is no deal on Britain’s departure from the European Union. While the EU and…

  • Pharma
  • November 15, 2018
  • 67 views
Zydus Cadila gets USFDA nod for leukemia treatment injection

New Delhi: Zydus Cadila Wednesday said it has received approval from the US health regulator to market Arsenic Trioxide injection, used to treat a type of leukemia. Zydus Cadila has…

  • Pharma
  • November 14, 2018
  • 92 views
Nifty Pharma index rises; Lupin, Cipla shares shine

NEW DELHI: Pharma shares were trading mixed with the Nifty Pharma index trading 0.2 per cent up at 9,663.1 around 12:12 pm on Monday. Shares of Lupin (up 1.64 per…

  • Pharma
  • November 14, 2018
  • 89 views
Bayer profit flat as weak animal health offsets strong Xarelto

By Ludwig Burger FRANKFURT: Bayer’s adjusted core earnings were flat for the quarter, as better prescription numbers for cardiovascular drug Xarelto were tempered by a weaker animal health business and…

  • Pharma
  • November 14, 2018
  • 70 views
Cipla’s subsidiary to acquire US-based Avenue Therapeutics for $ 215 million

Drug major Cipla Tuesday said its subsidiary InvaGen Pharmaceuticals Inc has entered into definitive agreements to acquire US-based speciality business firm Avenue Therapeutics for up to USD 215 million (around…

  • Pharma
  • November 14, 2018
  • 95 views
Aurobindo Pharma shares fall 3% after Q2 earnings

New Delhi: Shares of Aurobindo Pharma Tuesday fell almost 3 per cent after the company reported 21.70 per cent dip in consolidated net profit for the quarter ended September 30,…

  • Pharma
  • November 13, 2018
  • 97 views
Lupin launches generic pneumonia drug in US

New Delhi: Drug firm Lupin said Monday it has launched the generic Atovaquone oral suspension, which is used for the prevention and treatment of pneumonia, in the US market. The…

  • Pharma
  • November 13, 2018
  • 118 views
Cipla gets USFDA nod for anti-viral eye infection drug for AIDS patients

Drug major Cipla Monday said it has received final approval from the US health regulator for Valganciclovir tablets, used in the treatment of viral eye infection in AIDS patients. Valganciclovir…